Mohs Richard C, Greig Nigel H
Global Alzheimer's Platform Foundation, Washington, DC, USA.
Drug Design & Development Section, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD, USA.
Alzheimers Dement (N Y). 2017 Nov 11;3(4):651-657. doi: 10.1016/j.trci.2017.10.005. eCollection 2017 Nov.
This article provides a brief overview of the processes of drug discovery and development. Our aim is to help scientists whose research may be relevant to drug discovery and/or development to frame their research report in a way that appropriately places their findings within the drug discovery and development process and thereby support effective translation of preclinical research to humans. One overall theme of our article is that the process is sufficiently long, complex, and expensive so that many biological targets must be considered for every new medicine eventually approved for clinical use and new research tools may be needed to investigate each new target. Studies that contribute to solving any of the many scientific and operational issues involved in the development process can improve the efficiency of the process. An awareness of these issues allows the early implementation of measures to increase the opportunity for success. As editors of the journal, we encourage submission of research reports that provide data relevant to the issues presented.
本文简要概述了药物发现与开发的过程。我们的目的是帮助那些研究可能与药物发现和/或开发相关的科学家,以一种能将其研究结果恰当地置于药物发现与开发过程中的方式来撰写他们的研究报告,从而支持将临床前研究有效地转化到人体研究中。我们文章的一个总体主题是,这个过程足够漫长、复杂且昂贵,以至于对于每一种最终获批用于临床的新药,都必须考虑众多生物学靶点,并且可能需要新的研究工具来研究每个新靶点。有助于解决开发过程中所涉及的众多科学和操作问题中任何一个的研究,都可以提高该过程的效率。了解这些问题有助于尽早采取措施,增加成功的机会。作为该期刊的编辑,我们鼓励提交提供与所提出问题相关数据的研究报告。